The in vivo effects of rafoxanide on the energy metabolism of Fasciola hepatica.
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D004734:Energy Metabolism / Q000187:drug effects; D005210:Fasciola hepatica / Q000378:metabolism*; D005211:Fascioliasis / Q000378:metabolism / Q000662:veterinary; D005636:Fructosephosphates / Q000378:metabolism; D005958:Glucosephosphates / Q000378:metabolism; D006003:Glycogen / Q000378:metabolism; D011888:Rafoxanide / Q000494:pharmacology*; D012457:Salicylamides / Q000494:pharmacology*; D012756:Sheep; D012757:Sheep Diseases / Q000378:metabolism
D005636:Fructosephosphates; D005958:Glucosephosphates; D012457:Salicylamides; D011888:Rafoxanide; D000255:Adenosine Triphosphate; D006003:Glycogen